TANGO THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.44 USD | +1.50% |
|
+1.78% | -24.85% |
| 04-04 | British billionaire Joe Lewis fined $5 million by US judge for insider trading | RE |
| 04-04 | Multibillionaire Joe Lewis to face US sentencing for insider trading | RE |
Chart calendar Tango Therapeutics, Inc.
9870bf85b.SNcyied4PSrfjM17q2ypMSQG8o4F7rDdb2tA2CsXSTs.G_pTsZU-flyL3p0z-gPsBhB_uOdPh_OrGS4htBluHnUtolvzq0BLfpW0gA~b7c09f2a6a2452763d00887cf8ec4f84
Upcoming events on Tango Therapeutics, Inc.
Past events on Tango Therapeutics, Inc.
| 09/04/2024 21:30 | American Association for Cancer Research Meeting - Abstract No: 5584 |
| 09/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract No: 4631 |
| 09/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract No: 4636 |
| 08/04/2024 22:30 | American Association for Cancer Research Meeting - Abstract No: 3916 |
| 08/04/2024 21:30 | American Association for Cancer Research Meeting - Abstract No: 3363 |
| 08/04/2024 21:30 | American Association for Cancer Research Meeting - Abstract No: 3242 |
| 07/04/2024 21:30 | American Association for Cancer Research Meeting - Abstract No: 558 |
| 18/03/2024 11:00 | Q4 2023 Earnings Release |
| 13/03/2024 13:30 | Barclays Global Healthcare Conference |
| 12/03/2024 19:00 | Leerink Partners Global Biopharma Conference |
| 07/02/2024 16:30 | Guggenheim Healthcare Talks Biotechnology Conference |
| 18/11/2023 03:30 | Society for Neuro Oncology Meeting - Poster No #: EXTH-63 |
| 18/11/2023 03:30 | Society for Neuro Oncology Meeting - Poster NO #: DDDR-33 |
| 14/11/2023 | Society for Neuroscience Meeting |
| 14/11/2023 13:00 | Jefferies London Healthcare Conference |
| 08/11/2023 12:00 | Q3 2023 Earnings Release |
| 31/10/2023 | Society for Immunotherapy of Cancer Meeting |
| 14/10/2023 17:30 | AACR-NCI-EORTC International Conference - Poster No #: C048 |
| 13/10/2023 17:30 | AACR-NCI-EORTC International Conference - Poster No #: B054 |
| 13/10/2023 17:30 | AACR-NCI-EORTC International Conference - Poster No #: B098 |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 37,0 37,9 -2.3% | 24,9 24,8 0.35% | 36,5 38,6 -5.42% | 30,7 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -57,3 -58,9 2.7% | -109 -110 0.26% | -112 -106 -5.46% | -151 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -58,2 -59,1 1.61% | -111 -112 1.07% | -114 -111 -2.85% | -142 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -57,9 -58,4 0.72% | -108 -110 2.12% | -102 -101 -0.28% | -133 |
|
Net income Million USD | Released Forecast Spread | -52,0 | -58,2 -59,9 2.84% | -108 -111 2.61% | -102 -100 -1.34% | -132 |
|
EPS USD | Released Forecast Spread | -4,53 | -0,94 -1,28 26.27% | -1,23 -1,26 2.38% | -1,08 -1,07 -1.41% | -1,28 |
| Announcement Date | 20/04/21 | 28/03/22 | 27/03/23 | 18/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 5,72 6,57 -13.06% | 5,76 5,83 -1.31% | 5,77 5,66 1.97% | 6,92 5,64 22.64% | 6,41 6,32 1.37% | 5,77 6,77 -14.83% | 14,6 6,95 110.03% | 10,7 7,58 41.54% | 5,43 8,24 -34.07% | 7,51 | 7,84 | 7,67 | 7,69 | 6,25 |
|
EBIT Million USD | Released Forecast Spread | -22,0 -22,6 2.74% | -25,4 -24,0 -5.65% | -25,2 -27,2 7.4% | -29,9 -28,1 -6.66% | -30,6 -31,8 3.79% | -30,3 -31,8 4.9% | -23,2 -31,8 26.79% | -25,6 -32,3 20.66% | -35,0 -30,0 -16.86% | -32,9 | -34,4 | -35,9 | -38,6 | -34,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -21,9 -22,3 1.88% | -25,2 -24,8 -1.65% | -24,9 -26,5 6.05% | -29,1 -27,7 -4.75% | -29,0 -31,4 7.5% | -28,0 -31,0 9.55% | -20,6 -26,7 22.75% | -22,2 -30,4 26.85% | -30,7 -29,4 -4.36% | -31,4 | -32,5 | -33,5 | -35,3 | -33,5 |
|
Net income Million USD | Released Forecast Spread | -22,0 -23,7 7.15% | -25,2 -24,7 -2.26% | -24,9 -27,6 9.84% | -29,1 -28,0 -3.66% | -29,1 -32,0 9.1% | -28,0 -31,8 11.95% | -20,7 -27,7 25.28% | -22,3 -29,8 25.23% | -30,8 -28,6 -7.65% | -31,5 | -32,4 | -33,3 | -35,0 | -33,5 |
|
EPS USD | Released Forecast Spread | -0,26 -0,27 1.89% | -0,29 -0,28 -5.45% | -0,28 -0,31 9.68% | -0,33 -0,32 -3.94% | -0,33 -0,36 8.33% | -0,32 -0,35 9.22% | -0,23 -0,31 26.59% | -0,23 -0,34 31.34% | -0,30 -0,28 -5.88% | -0,31 | -0,32 | -0,32 | -0,33 | -0,32 |
| Announcement Date | 28/03/22 | 11/05/22 | 10/08/22 | 10/11/22 | 27/03/23 | 09/05/23 | 07/08/23 | 08/11/23 | 18/03/24 | - | - | - | - | - |
| Today 21:05 | QIAGEN N.V.: Q1 2024 Earnings Release |
| 29/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 11:30 | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 11:30 | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 12:00 | ALKERMES PLC: Q1 2024 Earnings Release |
| 01/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Tango Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TNGX Stock
- Calendar Tango Therapeutics, Inc.
